Table 3.
Adverse events.
Patients without any adverse event | 1036 (97.6%) |
Patients with adverse events possibly related to the treatmenta | 25 (2.4%) |
Diarrhea | 12 |
Abdominal pain | 3 |
Headache | 3 |
Nausea | 2 |
Insomnia | 2 |
Transient blurred vision | 2 |
Vomiting | 1 |
Urticaria | 1 |
Erythematous and bullous rash | 1 |
Discontinuation of treatment | 3 (abdominal pain, urticaria, erythematous and bullous rash) |
Some patients reported more than one adverse event.